Upcoming Webinars
Members and nonmembers are invited to register for all of our upcoming webinars.
Upcoming Webinars
Members and nonmembers are invited to register for all of our upcoming webinars.
September 3, 2026 | 2:00 pm
MARIJUANA Rescheduling and HEMP Criminalization: Updates & Implications for Financial Institutions
$225.00
What will be covered:
The cannabis industry and its regulatory environment are evolving rapidly, posing challenges to financial institutions’ ability to adequately assess, prepare for, and understand the implications of recent changes. This webinar will offer a practical perspective on navigating the shifting landscape and provide actionable tools that financial institutions can begin using immediately, regardless of their current cannabis-related policy and risk appetite. Topics include:
- Key definitions and classifications across the cannabis sector, including marijuana, hemp, and hemp-derived cannabinoid products
- Shifting legal and regulatory frameworks
- Significance of recent federal actions related to marijuana rescheduling and the recriminalization of most hemp-derived cannabinoid products
- Best practices based on YOUR institution’s risk appetite – whether you have a strict “no cannabis” policy, are considering a cannabis program, or actively accept cannabis deposits today
- Policy development and implementation
- Onboarding – KYC and EDD
- Effective screening and monitoring
- Tools and resources for policy development, risk mitigation, and regulatory compliance
Webinar attendees can expect to walk away with timely answers to their most pressing cannabis-related questions, including:
- What is the current status of marijuana under the Controlled Substances Act (CSA)?
- Are my current cannabis-related controls sufficient?
- Do I still need to file marijuana-related SARs on medical marijuana? What about SARs for hemp-related businesses?
- My institution prohibits marijuana and hemp. How will this impact us?
- There is no state-legal marijuana in our footprint. Why is this relevant to my institution?
- We’ve been banking on the sector for a long time. Does this really change anything?
- How do these changes impact risk assessments?
- What’s the best way to stay informed on what’s happening?
Presenters:
Jennifer Cliber Smith, CRCM, Compliance Anchor Director
Steven Kemmerling, Founder & CEO, CRB Monitor
WHO SHOULD ATTEND: Compliance Officers, Risk Management Officers and staff, Loan Compliance Personnel, Loan Officers, Loan Operations Staff, Board Members, Management
Steven Kemmerling is the Founder and CEO of CRB Monitor, the leading RegTech platform for cannabis-related business intelligence and compliance. With a database covering over 100,000 private cannabis businesses, 265,000 licenses, and 155,000 decision-makers, CRB Monitor serves as the single source of truth for financial institutions navigating the cannabis sector. Steven pioneered the industry’s risk-tiering framework, first introduced in his 2016 ACAMS Today white paper Defining Marijuana-Related Businesses, which has since become the standard used by banks and regulators nationwide. Before founding CRB Monitor, Steven worked as an M&A investment banker and securities litigation consultant.
